Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophilsin vitro
Open Access
- 1 August 1991
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 85 (2), 312-316
- https://doi.org/10.1111/j.1365-2249.1991.tb05725.x
Abstract
SUMMARY: The mechanisms that could affect the lifespan of eosinophils after they have left the bone marrow, and their capacity to respond to activation factors were studied by examining the effects of IL-5, GM-CSF and IL-3 on purified human blood eosinophils in culture. All three cytokines prolonged the lifespan of the majority of blood eosinophils. This effect was dose dependent: IL-5 > GM-CSF > IL-3. Light density eosinophils from most patients had a longer lifespan in culture than did normal density eosinophils, with or without the three cytokines. Eosinophil death in the absence of these cytokines occurred by apoptosis. Eosinophils from two patients did not survive when cultured with IL-5, although they survived in the presence of IL-3 or GM-CSF- IL-5, GM-CSF and IL-3 induced the expression of the activation epitope on the eosinophil ribonucleases recognized by monoclonal antibody EG2. We conclude that small amounts of IL-5, GM-CSF and IL-3 prevented programmed cell death in human blood eosinophils and induced the expression of the activation forms of eosinophil ribonucleases. We suggest that differences in the capacity of normal and light density eosinophils to survive in culture, and in the ability of eosinophils from some patients to respond to IL-5 could account for variations in the severity of disease seen in patients with persistent eosinophilia.Keywords
This publication has 23 references indexed in Scilit:
- Characterization of a receptor for interleukin 5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1990
- Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells.The Journal of Experimental Medicine, 1990
- Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosisNature, 1990
- Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome.The Journal of Experimental Medicine, 1989
- Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.Journal of Clinical Investigation, 1989
- Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.Journal of Clinical Investigation, 1988
- Recombinant human interleukin 5 is a selective activator of human eosinophil function.The Journal of Experimental Medicine, 1988
- Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.The Journal of Experimental Medicine, 1987
- Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.Journal of Clinical Investigation, 1986
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980